Monday, November 25, 2024
11/25/2024
The Institute for Family Health, a federally qualified health center (FQHC) network, will increase community access to FDA-approved overdose reversal drugs in partnership with community-based organizations and prescribers, resulting in a decrease in community risk for opioid overdose fatalities in two regions of New York State. PROJECT NAME: Improving Access to Overdose Treatment Program POPULATION(S) TO BE SERVED: The Institute will implement this project in two distinct regions of New York State – the Mid-Hudson Valley and New York City – both of which experience a disproportionate share of opioid dependence and associated overdoses related to prescription drug abuse, heroin use, and/or fentanyl ingestion. The Mid-Hudson Valley comprises New York’s largely rural and semi-rural counties of Ulster and Dutchess, and is affected by limited access to health care, transportation, and job opportunities. In New York City, a majority of overdose deaths occur in high-poverty neighborhoods, where the Institute and its partners are located. In both areas, men and younger people are most affected by the opioid crisis. STRATEGIES/INTERVENTIONS: To address this need, we will expand screening for overdose risk and distribution of opioid reversal drugs in our network of 32 community health centers; develop and launch a multi-pronged overdose prevention training program for community members and agencies; and provide linkage to treatment for patients who have experienced an overdose, or are at increased risk for overdose. PROJECT GOALS/MEASURABLE OBJECTIVES/NUMBER OF PEOPLE TO BE SERVED: The goal of this program is to increase community access to FDA-approved overdose reversal drugs, in partnership with community-based organizations and prescribers, resulting in a decrease in community risk for opioid overdose fatalities in two regions of New York State. Our program objectives are 1) By April 2020, expand screening for overdose risk and expand distribution and tracking of opioid reversal drugs in our network of 32 community health centers; 2) Beginning in 2019, develop and launch a multi-pronged overdose prevention training program, such that 300-500 individuals, 10-20 prescribers, 6-12 community organizations and/or pharmacies, and staff at 1-2 new overdose reversal drug distribution sites are trained or re-trained annually; and 3) Throughout the five-year project period, provide linkage to treatment for patients who have experienced an overdose or are at increased risk for overdose, such that an estimated 20-40 additional individuals access care for substance dependence annually.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
